Maximum tumor diameter is associated with relapse risk in limited-stage Hodgkin lymphoma: an international study

Abstract: Tumor bulk is an established prognostic factor in Hodgkin lymphoma (HL), but most patients with limited-stage (LS) HL do not have “bulk” by standard definitions. In the RAPID trial, maximum tumor diameter (MTD) was associated with relapse risk in LS-HL patients achieving positron emission...

Full description

Saved in:
Bibliographic Details
Main Authors: Elizabeth H. Phillips, Nicholas Counsell, Tim Illidge, Marc Andre, Igor Aurer, Valeria Fiaccadori, Catherine Fortpied, Anouk Neven, Massimo Federico, Sally F. Barrington, John Raemaekers, John Radford
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Blood Advances
Online Access:http://www.sciencedirect.com/science/article/pii/S2473952925000072
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items